Silva Miguel, Luís
Soares, Mariana
Olivieri, Anamaria
Sampaio, Filipa
Lamotte, Mark
Shukla, Suramya
Conde, Vasco
Freitas, Paula
Costa, João
Borges, Margarida
Article History
Received: 14 March 2024
Accepted: 15 April 2024
First Online: 30 April 2024
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare: MS, AVO, LSM and MB are employees of IQVIA. ML and SS were employees of IQVIA at the time of manuscript development. FS is employed by Uppsala University. JC is a member of Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de Lisboa. Both JC and FS are external consultants of IQVIA. VC is employed by Novo Nordisk. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.